• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

• 投稿 • 上一篇    下一篇

临床药师参与胸外科化疗患者医嘱审核干预效果分析

贾东丽,王天珩,井慧超   

  1. 邯郸市第一医院药学部,邯郸市第一医院药学部,邯郸市第一医院药学部
  • 收稿日期:2018-06-23 修回日期:2018-07-22 出版日期:2018-06-25

Effect Analysis of Participation of Clinical Pharmacists in Prescription Checking and Intervention in Thoracic Surgery

JIA Dongli,Wang Tianheng and Jing Huichao   

  1. Dept.of Pharmacy,First Hospital of Handan City,Hebei Handan,056002,Dept.of Pharmacy,First Hospital of Handan City,Hebei Handan,056002,Dept.of Pharmacy,First Hospital of Handan City,Hebei Handan,056002
  • Received:2018-06-23 Revised:2018-07-22 Online:2018-06-25

摘要: 目的:探讨临床药师参与胸外科化疗患者医嘱审核干预对促进临床合理用药的作用。方法:回顾性分析我院2016年8月至2017年7月临床药师参与胸外科化疗患者住院医嘱审核中发现的主要问题,并对我院胸外科2016年4~7月(干预前)、2016年8~11月(干预1阶段)、2016年12月至2017年3月(干预2阶段)、2017年4~7月(干预3阶段)所有化疗患者医嘱进行统计分析。结果:住院医嘱中不合理用药类型主要为溶媒种类及溶媒剂量选择不适宜、重复用药/不必要联合、用法用量不适宜、适应证不适宜、药物选择不适宜、配伍禁忌等。干预前我院胸外科化疗患者医嘱不合理率为6.47%,干预后1、2、3阶段分别下降至4.50%、2.70%、1.17%,与干预前比较差异均有统计学意义(P<0.05);干预后1、2、3阶段医师不合理医嘱修改率依次升高至50.27%、68.70%、87.04%,与干预1阶段比较差异均有统计学意义(P<0.05)。结论:临床药师参与医嘱审核干预有利于促进临床合理用药。

Abstract: Objective:To explore and investigate the effect of clinical pharmacists participating in medical prescription checking and intervention in the rational drug use of chemotherapy patients in thoracic surgery. Methods: Main problems found during clinical pharmacists participating in prescription checking in our hospital from August 2016 to July 2017 were analyzed respectively. Prescription of chemotherapy patients was analyzed statistically in thoracic surgery during April to July in 2016(before intervention), August to November in 2016(after the first intervention), December 2016 to March 2017(after the second intervention)and April to July in 2017(after the third intervention). Results: The irrational types in prescription included unsuitable solvent type and amount, inappropriate drug combination, unsuitable usage and dosage, inappropriate indications, unsuitable drug selection,incompatibility, and inappropriate treatment course,etc.The irrational rate of prescription of patients with chemotherapy was 6.47% before intervention, and 4.50%,2.70% and 1.17% after the first, second and third intervention respectively, the difference was statistically significant compared to before intervention(P<0.05). Recommended adoption rate for pharmacists rising in turn after the first, second and third intervention 50.27%, 68.70% and 87.04% respectively, the difference was statistically significant compared to the first intervention(P<0.05). Conclusion:Clinical pharmacists participate in medical prescription checking and intervention is propitious to rational drug use.